Schmelz Hubertus 5
5 · SANGUI BIOTECH INTERNATIONAL INC · Filed Sep 6, 2018
Insider Transaction Report
Form 5
Schmelz Hubertus
Director
Transactions
- Purchase
Common Stock
2016-10-19$0.03/sh+56,959$1,424→ 14,534,560 total - Purchase
Common Stock
2016-10-20$0.03/sh+100,000$3,000→ 14,666,381 total - Purchase
Common Stock
2017-05-26$0.04/sh+49,425$2,125→ 14,846,606 total - Purchase
Common Stock
2017-08-02$0.04/sh+41,875$1,675→ 14,930,481 total - Purchase
Common Stock
2017-08-03$0.03/sh+1,190,000$29,750→ 16,180,481 total - Purchase
Common Stock
2017-10-11$0.03/sh+1,190,000$29,750→ 18,610,481 total - Purchase
Common Stock
2017-11-13$0.04/sh+91,000$3,185→ 18,701,481 total - Purchase
Common Stock
2017-11-14$0.04/sh+20,000$740→ 18,721,481 total - Purchase
Common Stock
2016-10-14$0.04/sh+100,000$3,500→ 14,377,601 total - Purchase
Common Stock
2016-10-14$0.03/sh+100,000$3,300→ 14,477,601 total - Purchase
Common Stock
2016-10-19$0.03/sh+31,821$859→ 14,566,381 total - Purchase
Common Stock
2017-05-24$0.04/sh+50,000$1,950→ 14,797,181 total - Purchase
Common Stock
2016-12-27$0.04/sh+80,800$3,232→ 14,747,181 total - Purchase
Common Stock
2017-08-02$0.04/sh+42,000$1,596→ 14,888,606 total - Purchase
Common Stock
2017-08-02$0.04/sh+60,000$2,520→ 14,990,481 total - Purchase
Common Stock
2017-08-08$0.04/sh+50,000$2,050→ 16,230,481 total - Purchase
Common Stock
2018-01-23$0.04/sh+85,000$2,975→ 18,806,481 total - Purchase
Common Stock
2017-09-21$0.03/sh+1,190,000$29,750→ 17,420,481 total